Sonova Holding AG (SONVY)
USD 65.17
(0.11%)
USD 65.17
(0.11%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 3.3 Billion CHF | -0.62% |
| 2023 | 3.32 Billion CHF | 5.25% |
| 2022 | 3.15 Billion CHF | 0.07% |
| 2021 | 3.15 Billion CHF | 28.33% |
| 2020 | 2.45 Billion CHF | 28.21% |
| 2019 | 1.91 Billion CHF | 4.89% |
| 2018 | 1.82 Billion CHF | 1.26% |
| 2017 | 1.8 Billion CHF | 113.45% |
| 2016 | 845.34 Million CHF | 3.11% |
| 2015 | 819.82 Million CHF | 0.06% |
| 2014 | 819.37 Million CHF | -21.12% |
| 2013 | 1.03 Billion CHF | 28.94% |
| 2012 | 805.6 Million CHF | -2.58% |
| 2011 | 826.93 Million CHF | -22.1% |
| 2010 | 1.06 Billion CHF | 165.42% |
| 2009 | 399.93 Million CHF | 12.95% |
| 2008 | 354.07 Million CHF | -3.97% |
| 2007 | 368.7 Million CHF | 21.44% |
| 2006 | 303.6 Million CHF | 3.39% |
| 2005 | 293.65 Million CHF | -12.04% |
| 2004 | 333.86 Million CHF | 5.52% |
| 2003 | 316.4 Million CHF | -16.82% |
| 2002 | 380.38 Million CHF | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q4 | 3.3 Billion CHF | 1.34% |
| 2024 FY | 3.3 Billion CHF | -0.62% |
| 2024 Q2 | 3.25 Billion CHF | -1.94% |
| 2023 FY | 3.32 Billion CHF | 5.25% |
| 2023 Q2 | 3.19 Billion CHF | 1.3% |
| 2023 Q4 | 3.32 Billion CHF | 3.9% |
| 2022 FY | 3.15 Billion CHF | 0.07% |
| 2022 Q2 | 3.16 Billion CHF | 0.43% |
| 2022 Q4 | 3.15 Billion CHF | -0.36% |
| 2021 FY | 3.15 Billion CHF | 28.33% |
| 2021 Q4 | 3.15 Billion CHF | -0.42% |
| 2021 Q2 | 3.16 Billion CHF | 28.86% |
| 2020 Q4 | 2.45 Billion CHF | 8.75% |
| 2020 Q2 | 2.25 Billion CHF | 17.89% |
| 2020 FY | 2.45 Billion CHF | 28.21% |
| 2019 Q4 | 1.91 Billion CHF | -1.79% |
| 2019 Q2 | 1.95 Billion CHF | 6.8% |
| 2019 FY | 1.91 Billion CHF | 4.89% |
| 2018 Q2 | 1.82 Billion CHF | 0.91% |
| 2018 FY | 1.82 Billion CHF | 1.26% |
| 2018 Q4 | 1.82 Billion CHF | 0.34% |
| 2017 Q2 | 1.83 Billion CHF | 117.57% |
| 2017 Q4 | 1.8 Billion CHF | -1.89% |
| 2017 FY | 1.8 Billion CHF | 113.45% |
| 2016 FY | 845.34 Million CHF | 3.11% |
| 2016 Q4 | 845.34 Million CHF | 0.07% |
| 2016 Q2 | 844.77 Million CHF | 3.04% |
| 2015 Q2 | 752.1 Million CHF | -8.21% |
| 2015 FY | 819.82 Million CHF | 0.06% |
| 2015 Q4 | 819.82 Million CHF | 9.0% |
| 2014 Q4 | 819.37 Million CHF | -17.61% |
| 2014 Q2 | 994.48 Million CHF | -4.26% |
| 2014 FY | 819.37 Million CHF | -21.12% |
| 2013 Q2 | 781.6 Million CHF | -2.98% |
| 2013 Q4 | 1.03 Billion CHF | 32.9% |
| 2013 FY | 1.03 Billion CHF | 28.94% |
| 2012 Q4 | 805.6 Million CHF | 1.2% |
| 2012 FY | 805.6 Million CHF | -2.58% |
| 2012 Q2 | 796.02 Million CHF | -3.74% |
| 2011 FY | 826.93 Million CHF | -22.1% |
| 2011 Q4 | 826.93 Million CHF | -9.4% |
| 2011 Q2 | 912.75 Million CHF | -14.01% |
| 2010 FY | 1.06 Billion CHF | 165.42% |
| 2010 Q4 | 1.06 Billion CHF | 0.0% |
| 2009 FY | 399.93 Million CHF | 12.95% |
| 2008 FY | 354.07 Million CHF | -3.97% |
| 2007 FY | 368.7 Million CHF | 21.44% |
| 2006 FY | 303.6 Million CHF | 3.39% |
| 2005 FY | 293.65 Million CHF | -12.04% |
| 2004 FY | 333.86 Million CHF | 5.52% |
| 2003 FY | 316.4 Million CHF | -16.82% |
| 2002 FY | 380.38 Million CHF | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AVITA Medical, Inc. | 19.86 Million USD | -16514.312% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | -155730.973% |
| Össur hf. | 688.8 Million USD | -379.162% |
| QHSLab, Inc. | 2.05 Million USD | -160348.293% |
| Wellstar International, Inc. | 55.99 Million USD | -5794.745% |
| Össur hf. | 688.8 Million USD | -379.162% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 2.94 Million USD | -111844.234% |
| Aurora Spine Corporation | 6.65 Million USD | -49505.202% |
| BrainsWay Ltd. | 15.31 Million USD | -21452.174% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 16.62 Million USD | -19755.251% |
| Hamilton Thorne Ltd. | 45.84 Million USD | -7099.6% |
| Vivos Inc. | 245 Thousand USD | -1347020.863% |
| Kelyniam Global, Inc. | 1.01 Million USD | -325735.32% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -1197408.109% |
| Zecotek Photonics Inc. | 5.86 Million USD | -56139.932% |
| Avitar, Inc. | 11.59 Million USD | -28368.45% |
| Nanomix Corporation | 14.81 Million USD | -22178.477% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | -20424.815% |
| Theraclion SA | 13.01 Million EUR | -25256.144% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 2.02 Million USD | -162807.367% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | -91044.575% |
| Lombard Medical, Inc. | 53.79 Million USD | -6035.443% |
| ALR Technologies Inc. | 24.5 Million USD | -13368.482% |
| Stratec SE | 271.97 Million USD | -1113.551% |
| Vycor Medical, Inc. | 4.31 Million USD | -76339.851% |
| Heart Tronics, Inc. | 1.09 Million USD | -301373.617% |
| MicroPort Scientific Corporation | 2.48 Billion USD | -32.743% |
| VMS Rehab Systems, Inc. | 201.36 USD | -1639103992.173% |
| NewCardio, Inc. | 6.01 Million USD | -54792.629% |
| Guided Therapeutics, Inc. | 5.47 Million USD | -60183.105% |
| Ingen Technologies, Inc. | 5.7 Million USD | -57706.688% |
| Odyssey Group International, Inc. | 6.61 Million USD | -49818.917% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | -134624.844% |
| Wellness Center USA, Inc. | 5.12 Million USD | -64310.092% |
| SANUWAVE Health, Inc. | 65.59 Million USD | -4931.71% |
| IR-Med Inc. | 634 Thousand USD | -520483.596% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | -60165.867% |
| Polarean Imaging plc | 2.58 Million USD | -127799.636% |
| United American Healthcare Corporation | 119 Thousand USD | -2773429.412% |
| ECGI Holdings, Inc. | 11.94 Million USD | -27541.543% |
| Nu-Med Plus, Inc. | 2.35 Million USD | -139823.673% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -249185.49% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -228097.163% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -486975.276% |
| Urologix, Inc. | 12.64 Million USD | -26003.29% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | -61064.964% |
| Nexeon MedSystems Inc. | 8.48 Million USD | -38809.726% |
| SS Innovations International, Inc. | 11.18 Million USD | -29418.557% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -628103.591% |
| Smith & Nephew plc | 4.76 Billion USD | 30.709% |
| NIOX Group Plc | 9.8 Million USD | -33571.356% |
| Fuse Medical, Inc. | 15.11 Million USD | -21743.056% |
| Broncus Holding Corporation | 10.43 Million USD | -31537.719% |
| Brain Scientific Inc. | 7.42 Million USD | -44342.781% |
| Pressure BioSciences, Inc. | 33.8 Million USD | -9663.78% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -415537.699% |